GLP1R and type 2 diabetes mellitus: As shown in the representative sets of experiment (Fig. 2), linagliptin treatment significantly increased GLP-1 concentration in the culture media of both ND and T2D islets in a dose-dependent manner, with the highest concentrations reaching ~5 times of that in untreated groups (Fig. 2A,B).